Xenon Pharmaceuticals Inc (XENE) — Free Cash Flow Generation Index

Latest as of December 2019: 0.97x

Xenon Pharmaceuticals Inc (XENE) has a Free Cash Flow Generation Index of 0.97x as of December 2019. Free cash flow of $19.14 Million represents 1% of operating cash flow ($19.73 Million). Read Xenon Pharmaceuticals Inc balance sheet liabilities for a breakdown of total debt and financial obligations.

FCF Generation Index

0.97x
Free Cash Flow / Operating CF

Free Cash Flow

$19.14 Million
USD

Operating Cash Flow

$19.73 Million
USD

Capital Expenditures

$595.00K
USD

Xenon Pharmaceuticals Inc Free Cash Flow Generation Index (2012–2014)

Historical FCF Generation Index trend for Xenon Pharmaceuticals Inc across 2 annual periods. Explore capital reinvestment ratio of Xenon Pharmaceuticals Inc to see what proportion of operating cash flow is directed to capital expenditures.

Annual Free Cash Flow Generation for Xenon Pharmaceuticals Inc (2012–2014)

Year-by-year Free Cash Flow Generation Index for Xenon Pharmaceuticals Inc. For the full company profile including market capitalisation, see XENE stock market capitalisation.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2014 -4.75x $-1.26 Million $266.00K $1.53 Million ▼ -580.4%
2012 0.99x $45.05 Million $45.57 Million $526.00K
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).